AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
Acquiring Company
Vertex Pharmaceuticals
Acquired Company
Crinetics Pharmaceuticals
BostonSan DiegoBiotechnologyHealth CareTherapeuticsBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals in an all-cash transaction valued at approximately $10 billion. The acquisition grants Vertex access to Crinetics' endocrine portfolio, enhancing its service offerings. This deal marks Vertex's largest acquisition to date and follows significant stock performance for both companies.
Fundz sees it the moment Vertex Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals was acquired by Vertex Pharmaceuticals, based in Boston. The deal was reported on September 20, 2026. Vertex is a global biotechnology company focused on innovative medicines for serious diseases. Vertex Pharmaceuticals is publicly traded (VRTX) and operates in Biotechnology.
When did Vertex Pharmaceuticals acquire Crinetics Pharmaceuticals?
Vertex Pharmaceuticals's acquisition of Crinetics Pharmaceuticals was reported on September 20, 2026. Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals in an all-cash transaction valued at approximately $10 billion. The acquisition grants Vertex access to Crinetics' endocrine portfolio, enhancing its service offerings. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Crinetics Pharmaceuticals do?
Crinetics Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors. It is privately held, operating in Biotechnology, and is based in San Diego.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.